Rare diseases
Investigational molecules
Locations
QTX-2101 and Arsenic Trioxide in Adult Patients With Acute Promyelocytic Leukemia
ItalyObrixtamig, Carboplatin, and Etoposide for First-Line Treatment of Advanced Extrapulmonary Neuroendocrine Carcinoma in DLL3-Positive Patients
ItalyRO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes
ItalyA Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer
ItalyPhase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients
ItalyRO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes
ItalyA study to evaluate the safety and effectiveness of rilvegostomig, ramucirumab, and a drug combination in adults with advanced or metastatic non-small cell lung cancer
ItalyA study to evaluate the safety of OMN6 in patients with pneumonia caused by Acinetobacter baumannii bacteria.
ItalyLong-Term Study of Imeroprubart in Adults With Graves' Disease
ItalyBMN 333 Versus Vosoritide in Children With Achondroplasia
ItalyCenegermin Eye Drops for Persistent Corneal Epithelial Defect in Patients with Persistent Corneal Epithelial Defect
ItalyFWY003 in Geographic Atrophy Secondary to Age-Related Macular Degeneration in Patients
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
